Abbvie Inc (ABBV) concluded trading on Wednesday at a closing price of $196.82, with 2.88 million shares of worth about $567.36 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 10.99% during that period and on October 02, 2024 the price saw a loss of about -0.07%. Currently the company’s common shares owned by public are about 1.77B shares, out of which, 1.76B shares are available for trading.
Stock saw a price change of 2.91% in past 5 days and over the past one month there was a price change of -0.44%. Year-to-date (YTD), ABBV shares are showing a performance of 27.01% which increased to 32.76% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $135.85 but also hit the highest price of $199.95 during that period. The average intraday trading volume for Abbvie Inc shares is 4.76 million. The stock is currently trading 1.17% above its 20-day simple moving average (SMA20), while that difference is up 2.49% for SMA50 and it goes to 13.16% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Abbvie Inc (NYSE: ABBV) currently have 1.77B outstanding shares and institutions hold larger chunk of about 73.05% of that.
The stock has a current market capitalization of $347.65B and its 3Y-monthly beta is at 0.62. PE ratio of stock for trailing 12 months is 65.83, while it has posted earnings per share of $2.99 in the same period. Its PEG reads 10.51 and has Quick Ratio of 0.71 while making debt-to-equity ratio of 10.42. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ABBV, volatility over the week remained 1.82% while standing at 1.75% over the month.
Stock’s fiscal year EPS is expected to drop by -2.11% while it is estimated to increase by 11.36% in next year. EPS is likely to grow at an annualized rate of 6.26% for next 5-years, compared to annual growth of -5.77% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by HSBC Securities on June 05, 2024 offering a Buy rating for the stock and assigned a target price of $185 to it. Coverage by Cantor Fitzgerald stated Abbvie Inc (ABBV) stock as an Overweight in their note to investors on May 17, 2024, suggesting a price target of $200 for the stock. Stock get a Buy rating from Goldman on December 11, 2023.
